Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 22, 2003

View Archived Issues

Adenosine alleviates neuropathic pain in humans

Advantages for insulin/metformin vs. triple oral therapy in type 2 diabetes

Pentostatin in children with chronic GVHD

HDAC inhibitors reported to be potentially useful in controlling cardiac hypertrophy

Antiinflammatory effects described for IS-741 in a rat model of IBD

AVI BioPharma cleared to begin phase Ib trial of West Nile virus antisense drug

Abbott and Millennium end research alliance

Health Canada approves Gamunex

SuperGen discusses Orathecin rolling NDA submission plans with FDA

Genta to acquire Salus Therapeutics

Preliminary results of North American Cystistat trial for interstitial cystitis

Corixa and Apovia enter RC-529 agreement

Engitech to commercialize and market Alferon N in the U.S.

ImClone submits Erbitux BLA

Substance P-derived peptides with NK1-antagonist activity and their use as antitumor agents

Quinazoline-based fungal efflux pump inhibitors newly developed at Essential Therapeutics

Eisai claims novel proteasome inhibitors with utility as antitumor agents

Novel PPARalpha agonists under study at Sigma-Tau

New MMP inhibitors in early development at Leo Pharma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...